Clinical Trial Update: Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update describing the use of hydroxyurea with precision medicine approaches to improve utilization and safety for sickle cell disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Brown University | Conditions: Sickle Cell Anemia in Children, Sickle Cell Disease | Phase 3 | Status: RECRUITING